Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China

BACKGROUND: Coronavirus Disease 2019 (COVID-19) is an emerging and rapidly evolving disease, with no recommended effective anti-coronavirus drug treatment. Traditional Chinese Patent Medicines (CPMs) have, however, been widely used to treat COVID-19 in China, and a number of clinical practice result...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Wei, Fan, Zheng, Chu, Yanqi, Wang, Haizheng, Yang, Ying, Wu, Li, Sun, Nan, Sun, Ge, Shen, Yuqiao, Lin, Xiaolan, Guo, Guiming, Xi, Shengyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396557/
https://www.ncbi.nlm.nih.gov/pubmed/32848729
http://dx.doi.org/10.3389/fphar.2020.01066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396557/
https://www.ncbi.nlm.nih.gov/pubmed/32848729
http://dx.doi.org/10.3389/fphar.2020.01066

Ejemplares similares